XIAMEN KINGDOMWAY GROUP COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.68 CNY | +5.23% |
|
+6.38% | -10.10% |
| Sales 2022 | 3.01B 416M 34.68B | Sales 2023 | 3.1B 429M 35.76B | Capitalization | 9.96B 1.38B 115B |
|---|---|---|---|---|---|
| Net income 2022 | 257M 35.5M 2.96B | Net income 2023 | 277M 38.27M 3.19B | EV / Sales 2022 | 4.3 x |
| Net Debt 2022 | 293M 40.54M 3.38B | Net cash position 2023 | 16.47M 2.28M 190M | EV / Sales 2023 | 3.2 x |
| P/E ratio 2022 |
48.2
x | P/E ratio 2023 |
36.3
x | Employees | 2,907 |
| Yield 2022 |
0.97% | Yield 2023 |
-
| Free-Float | 40.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.23% | ||
| 1 week | +6.38% | ||
| Current month | -6.32% | ||
| 1 month | -6.32% | ||
| 3 months | +8.10% | ||
| 6 months | -18.94% | ||
| Current year | -10.10% |
1 week
13.64
14.84
1 month
12.8015.69
Current year
10.7116.48
1 year
10.7121.16
3 years
10.7151.23
5 years
10.7164.48
10 years
8.1564.48
| Managers | Title | Age | Since |
|---|---|---|---|
Bin Jiang
CEO | Chief Executive Officer | 57 | 01/97/01 |
Hang Hong
DFI | Director of Finance/CFO | 42 | 12/16/12 |
Jia Liang Chen
BRD | Director/Board Member | 60 | 01/01/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shui Hua Wang
BRD | Director/Board Member | 58 | 20/15/20 |
Bin Jiang
CEO | Chief Executive Officer | 57 | 01/97/01 |
Jia Liang Chen
BRD | Director/Board Member | 60 | 01/01/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.54% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 14.68 | +5.23% | 9,486,137 |
| 26/24/26 | 13.95 | -0.78% | 6,477,183 |
| 25/24/25 | 14.06 | +1.88% | 4,991,300 |
| 24/24/24 | 13.8 | -0.22% | 4,522,433 |
| 23/24/23 | 13.83 | +0.22% | 5,330,369 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.
Sector
Food Processing
Calendar
30/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.10% | 1.24B | |
| +11.32% | 8.01B | |
| +1.64% | 7.36B | |
| +10.50% | 6.54B | |
| -6.69% | 3.73B | |
| -13.51% | 3.42B | |
| +8.34% | 935M | |
| -41.81% | 886M | |
| -19.81% | 827M | |
| -16.48% | 804M |
- Stock Market
- Equities
- 002626 Stock
